LifeVantage Corporation — Form 10-Q Summary
Reporting period: Quarter and nine months ended March 31, 2017. Although the request identifies “2016 Q3,” this filing covers fiscal 2017’s third quarter, with comparable periods ended March 31, 2016. Amounts are in U.S. dollars; financial statement amounts below are in millions unless stated otherwise.
Business context
LifeVantage sells nutraceutical, skin-care, energy, and weight-management products through independent distributors and customers in the Americas and Asia/Pacific & Europe. Its business depends substantially on the number and productivity of active distributors and preferred customers.
Financial results and liquidity
| Metric | Three months ended Mar. 31 | Nine months ended Mar. 31 |
|---|---|---|
| Revenue, 2017 / 2016 | $45.0 / $56.2 | $148.8 / $153.5 |
| Gross profit, 2017 / 2016 | $36.8 / $46.4 | $124.3 / $129.0 |
| Gross margin, 2017 / 2016 | 81.7% / 82.7% | 83.5% / 84.0% |
| Operating income, 2017 / 2016 | $0.2 / $3.6 | $2.9 / $9.3 |
| Net income, 2017 / 2016 | $0.1 / $1.0 | $1.5 / $3.7 |
| Diluted earnings per share, 2017 / 2016 | $0.00 / $0.07 | $0.11 / $0.26 |
- Third-quarter revenue fell 19.9%; nine-month revenue declined 3.0%. Operating income and net income also decreased substantially in both comparisons.
- Quarterly operating expenses were $36.6 million, or 81.2% of revenue, versus $42.8 million, or 76.2%, a year earlier. Nine-month operating expenses rose to $121.4 million from $119.6 million.
- For the nine months, operating cash flow was $4.6 million, down from $6.2 million. Investing cash use was $0.5 million; financing cash use was $2.8 million. Cash increased $1.3 million to $9.2 million from June 30, 2016.
- At March 31, cash was $9.2 million, working capital was $12.9 million, and total debt principal was $8.0 million ($2.0 million current and $6.0 million long-term). The term loan carries a fixed 4.93% rate and matures March 30, 2019. The company reported compliance with its credit-facility covenants.
- Total assets were $46.7 million and stockholders’ equity was $13.9 million at March 31, 2017. Inventory was $19.1 million, down from $25.1 million at June 30, 2016.
Material changes and management commentary
- Revenue fell in the Americas by 21.9% for the quarter and 5.6% year to date. Asia/Pacific & Europe revenue decreased 12.5% in the quarter but increased 5.8% year to date; Japan grew year to date, while Hong Kong revenue declined sharply.
- Management attributed lower sales partly to fewer active customers and distributors, lower event-related revenue, and restrictions introduced after an Audit Committee review to address distribution into countries with registration or direct-selling restrictions. The company expects future sales carried or shipped into those countries to be significantly lower than in fiscal 2016.
- Active preferred customers declined 5.9% year over year to 111,000; active distributors declined 11.3% to 63,000. Asia/Pacific & Europe active distributors fell 22.7%.
- Gross margin declined as a result of inventory obsolescence, storage, handling and shipment costs, and product mix. The company recorded $0.4 million of inventory obsolescence costs in the quarter.
- Nine-month selling, general and administrative expense increased by $6.6 million, primarily reflecting legal and accounting costs for the Audit Committee review and higher personnel-related costs. Management expected SG&A as a percentage of revenue to decrease slightly during the remainder of fiscal 2017 and commissions and incentives to remain fairly consistent with year-to-date levels.
Outlook, risks, contingencies, and unusual items
- Management expects revenue growth initiatives to include distributor tools, training and technology, new products, and expanded international marketing. It expects moderate growth in Asia/Pacific & Europe, while emphasizing compliance with local customs, tax and regulatory requirements. No specific numerical revenue or earnings guidance is provided.
- Management stated cash and expected operating cash flow should meet requirements for at least the next 12 months. The credit facility restricts additional borrowing and certain equity transactions; raising additional funds may not be available on acceptable terms.
- Disclosure controls and procedures were deemed ineffective as of March 31, 2017 because of a material weakness in internal control over financial reporting concerning international business policies, monitoring and training. Remediation was underway, but management could not estimate when it would be complete.
- A securities class action and several shareholder derivative actions allege misleading disclosures relating to internal controls and fiscal 2016 results. The company had not accrued a loss, stating liability was not probable or estimable; it warned an unfavorable outcome could materially affect the business or financial condition. A separate former-distributor lawsuit was settled confidentially, with all claims dismissed with prejudice.
- The company identified related-party arrangements, including marketing and consulting services and expected software-development payments. It also reported a $2.7 million fiscal 2017 payment to Real Salt Lake under a marketing partnership; the team’s owner was a 5% stockholder.
- Foreign currency is a material exposure: a hypothetical 10% strengthening of the U.S. dollar against relevant currencies would have reduced nine-month revenue by approximately $3.7 million, or 2.5%.
Important facts for investors to verify
- Whether distributor and customer declines, and the new restrictions on cross-border product distribution, continue to weigh on revenue—particularly in the Americas and Hong Kong.
- Progress and effectiveness of remediation for the disclosed material weakness, and any further developments from the Audit Committee review or related securities and derivative litigation.
- Cash generation, inventory valuation and obsolescence, and compliance with the credit facility’s financial covenants as sales and earnings change.
- Whether management’s stated growth initiatives and expense expectations translate into improved revenue, margins, and profitability.
- Potential costs or conflicts associated with related-party arrangements and the outcomes of the pending legal matters, for which no loss amount is clearly estimable in the filing.